1. Home
  2. SRRK vs PTY Comparison

SRRK vs PTY Comparison

Compare SRRK & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • PTY
  • Stock Information
  • Founded
  • SRRK 2012
  • PTY 2002
  • Country
  • SRRK United States
  • PTY United States
  • Employees
  • SRRK N/A
  • PTY N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • PTY Investment Managers
  • Sector
  • SRRK Health Care
  • PTY Finance
  • Exchange
  • SRRK Nasdaq
  • PTY Nasdaq
  • Market Cap
  • SRRK 2.9B
  • PTY 2.4B
  • IPO Year
  • SRRK 2018
  • PTY N/A
  • Fundamental
  • Price
  • SRRK $30.75
  • PTY $13.17
  • Analyst Decision
  • SRRK Strong Buy
  • PTY
  • Analyst Count
  • SRRK 6
  • PTY 0
  • Target Price
  • SRRK $42.17
  • PTY N/A
  • AVG Volume (30 Days)
  • SRRK 1.6M
  • PTY 550.4K
  • Earning Date
  • SRRK 05-06-2025
  • PTY 01-01-0001
  • Dividend Yield
  • SRRK N/A
  • PTY 9.65%
  • EPS Growth
  • SRRK N/A
  • PTY N/A
  • EPS
  • SRRK N/A
  • PTY N/A
  • Revenue
  • SRRK N/A
  • PTY N/A
  • Revenue This Year
  • SRRK N/A
  • PTY N/A
  • Revenue Next Year
  • SRRK $601.05
  • PTY N/A
  • P/E Ratio
  • SRRK N/A
  • PTY N/A
  • Revenue Growth
  • SRRK N/A
  • PTY N/A
  • 52 Week Low
  • SRRK $6.76
  • PTY $11.92
  • 52 Week High
  • SRRK $46.98
  • PTY $14.88
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 49.04
  • PTY 38.02
  • Support Level
  • SRRK $28.79
  • PTY $12.61
  • Resistance Level
  • SRRK $31.09
  • PTY $13.52
  • Average True Range (ATR)
  • SRRK 2.50
  • PTY 0.49
  • MACD
  • SRRK 0.44
  • PTY -0.04
  • Stochastic Oscillator
  • SRRK 78.82
  • PTY 51.58

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

Share on Social Networks: